A new pill developed by the British pharmaceutical firm AstraZeneca appears to help people lose a similar amount of weight as other oral GLP-1 drugs, trial results showed Monday. If confirmed by ...

Share on Pinterest AstraZeneca’s new oral GLP-1 pill showed promising results for weight loss and blood sugar in a phase 2 trial. Guido Mieth/Getty Images A new GLP-1 oral medication from AstraZeneca, ...

Weight loss drugs are gaining immense attention and the race to develop effective weight-loss medicines is becoming increasingly competitive. AstraZeneca has now entered the spotlight with encouraging ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A new GLP-1 oral tablet has shown promising results in a phase 2b clinical trial for the treatment of type 2 diabetes. Officials at AstraZeneca report that their new medication, elecoglipron, helped ...

AstraZeneca has outlaid up to $18.5bn in a licensing deal with China-based CSPC Pharmaceuticals to develop longer lasting weight-loss drugs, becoming the latest drugmaker to eye entry into the ...